Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
about
Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Compound genetically engineere ...... on angiogenic TGF-β signaling.
@en
type
label
Compound genetically engineere ...... on angiogenic TGF-β signaling.
@en
prefLabel
Compound genetically engineere ...... on angiogenic TGF-β signaling.
@en
P2093
P2860
P50
P356
P1433
P1476
Compound genetically engineere ...... on angiogenic TGF-β signaling
@en
P2093
Eliane Cortez
Sara I Cunha
Se-Jin Lee
P2860
P304
84314-84325
P356
10.18632/ONCOTARGET.12604
P407
P577
2016-12-01T00:00:00Z